Speciality pharmaceutical company Alliance Pharma has agreed to acquire exclusive marketing rights to medical anti-dandruff shampoo brand Nizoral in the Asia-Pacific region from Johnson & Johnson subsidiary Janssen Pharmaceutica, it announced on Tuesday, for a total consideration of £60m. The AIM-traded firm said the acquisition, which would boost Alliance's "successful and rapidly growing" APAC distributor business, was expected to be materially earnings-enhancing in the first full year of ...Den vollständigen Artikel lesen ...
© 2018 LiveCharts.co.uk